MediSieve have recently
been announced winners of the CMS Healthcare Startup of the Year Award 2017 in
the Beanstalks competition.
This news was announced at
the GIANT Health Event, held at the Old Truman Brewery in London from 8-10
November. The prestigious award, now in its second year, was given to the
startup medical company for their advances in magnetic blood filtration.
The Beanstalk Awards are a competition for
startup companies with ideas, prototypes or advancements in the medical sector.
The awards aim to celebrate, encourage and reward innovation within the medical
sector, where entrepreneurs are making great strides towards actionable
advances in technology in order to tackle some of our biggest diseases and
conditions we are facing in today's world.
Following their nomination for the TCT Magazine
awards 2017 in the Healthcare Application category, the win comes as a shining
example of the life-saving work MediSieve are continuing to be a part of and
has instilled great confidence and pride into the heart of the company.
The award for CMS Healthcare Startup of the Year
as part of the Beanstalks competition will allow MediSieve to expand their
business in new and exciting ways. As a reward for winning this prestigious
prize, the company is entitled to a package of legal services which are worth
anything up to the value of £8,000, as kindly provided by CMS. This will be tailored
to the company's needs, and will allow them to develop in any legal area they
choose, including everything from the development of new technology and
patents, through to commercial contracts and share schemes. MediSieve are
excited about what this will mean for their future, and for their development
as a company who are passionate about bringing brilliant new ideas into the
healthcare industry.
George Frodsham, founder and CEO MediSieve said:
"It's an amazing achievement and we're all happy to have won the
Beanstalks Competition Healthcare Startup of the Year award. Everyone has
worked incredibly hard on our magnetic blood filtration device, and it's great
to see all that work and the future applications being recognised. We're still
working on ways to improve the device, to be able to broaden its applications
and help to tackle some of the challenges that affect us all".
The MediSieve device, an innovative medical
blood-filtration device that magnetically filters particles from the
bloodstream, is still undergoing extensive testing and research to be able to
target the causes of specific diseases, such as sepsis and leukaemia, and is
hoped to be able to improve treatments for cases of malaria.
Amir Amraie from GIANT
Health Events said "our vision is to improve the health and well-being of
people around the world, by promoting healthcare innovation and supporting
health-tech entrepreneurs. And I believe with all and every one of you we were
able to achieve this. This year we had over 100 health entrepreneurs from 18
countries applying and you are doing great work with MediSieve Limited."
All of those who worked
tirelessly on MediSieve's product and on ensuring it becomes an established
product within the healthcare industry are incredibly proud of their
achievement.
To find out more about the Beanstalks Awards,
visit http://beanstalks.gianthealthevent.com/
For
editorial enquiries, contact 0131 357 8977 or email pr@redheadpr.co.uk
Ends
Follow
redheadPR on Twitter and like them
on Facebook
Visit www.redheadpr.co.uk
Find
out more about founder and managing director, Sara Tye